OPTHEA

Opthea Limited (NASDAQ: OPT, ASX: OPT) is a global biopharmaceutical company aspiring to become the leader of therapeutic innovation in retinal diseases... Opthea is a global biopharmaceutical company dedicated to improving and protecting vision in people with retinal disease... Our board believes in the promising future of our company and in the power of our transformational science and technology to establish a new standard-of-care for retinal diseases. Our board members bring the strategic expertise and necessary skills needed to help the company succeed, and collectively they provide important oversight and governance of the business.

Also known as: Opthea Limited, Opthea Limited, Inc, Opthea US, Inc., Opthea, Ltd.

Primary location: Princeton United States